Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
Boehringer Ingelheim
Accenture
Harvard Business School
US Department of Justice
Merck
Johnson and Johnson
Teva

Generated: October 23, 2018

DrugPatentWatch Database Preview

TRECATOR Drug Profile

« Back to Dashboard

When do Trecator patents expire, and what generic alternatives are available?

Trecator is a drug marketed by Wyeth Pharms and is included in one NDA.

The generic ingredient in TRECATOR is ethionamide. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ethionamide profile page.

Drug patent expirations by year for TRECATOR
Pharmacology for TRECATOR
Medical Subject Heading (MeSH) Categories for TRECATOR
Synonyms for TRECATOR
.alpha.-Ethyl-thioisonicotinamide
.alpha.-Ethylisonicotinic acid thioamide
.alpha.-Ethylisonicotinoylthioamide
.alpha.-Ethylisothionicotinamide
.alpha.-Ethylthioisonicotinamide
1314 TH
1314 TN
1314-Th
1314TH
2-e thylisothionicotinamide
2-ethyl-4-aminothiocarbonylpyridine
2-ETHYL-4-PYRIDINECARBOTHIOAMIDE
2-Ethyl-4-thioamidylpyridine
2-Ethyl-4-thiocarbamoylpyridine
2-ethyl-4-thiopyridylamide
2-Ethyl-thioisonicotinamide
2-Ethylisonicotinic acid thioamide
2-ethylisonicotinic acid thiomide
2-Ethylisonicotinic thioamide
2-Ethylisonicotinothiamide
2-Ethylisonicotinothioamide
2-Ethylisonicotinoylthioamide
2-Ethylisonicotinthioamide
2-Ethylisothionicotinamide
2-ethylpyridine-4-carbothioamide
2-Ethylthioisonicotinamide
2-ethylthioisonicotinamide, Trecator SC, Amidazine, Ethionamide
2-ethylthioisonicotinamide;Trecator SC;Amidazine
3-Ethylisothionicotinamide
33010-EP2286812A1
33010-EP2287165A2
33010-EP2287166A2
33010-EP2292620A2
33010-EP2297130A1
33010-EP2301536A1
33010-EP2301538A1
33010-EP2305675A1
33010-EP2305695A2
33010-EP2305696A2
33010-EP2305697A2
33010-EP2305698A2
33010-EP2305808A1
33010-EP2308833A2
33010-EP2308852A1
33010-EP2308874A1
33010-EP2311455A1
33010-EP2311815A1
4-Pyridinecarbothioamide, 2-ethyl-
5-22-02-00360 (Beilstein Handbook Reference)
536-33-4
73833-EP2308926A1
73833-EP2309564A1
A829694
AB00051990
AB00051990_10
AB00051990_11
AB00051990-09
AB0015183
AB2000288
AC-13715
AC1MC4CB
AEOCXXJPGCBFJA-UHFFFAOYSA-
AEOCXXJPGCBFJA-UHFFFAOYSA-N
Aethionamidum
Aetina
Aetiva
AK163496
AKOS006220662
alpha-Ethylisonicotinic acid thioamide
alpha-Ethylisonicotinoylthioamide
alpha-Ethylisothionicotinamide
alpha-ethylt hioisonicotinamide
alpha-Ethylthioisonicotinamide
Amidazin
Amidazine
amino(2-ethyl(4-pyridyl))methane-1-thione
AN-45683
ANW-42028
Atina
AX8010649
Bayer 5312
Bayer5312
BPBio1_000563
BRD-K33710385-001-05-4
BRN 0116474
BSPBio_000511
BSPBio_002016
C-04805
C07665
C8H10N2S
CAS-536-33-4
CC-27545
CCG-40212
CCRIS 287
CHEBI:4885
CHEMBL1441
CJ-10999
CPD001370750
CS-2266
CTK3J2408
D00591
D0P0HB
DB00609
DivK1c_000145
DR000187
DSSTox_CID_577
DSSTox_GSID_20577
DSSTox_RID_75669
DTXSID0020577
E0695
EINECS 208-628-9
Ethatyl
Ethimide
Ethina
Ethina (VAN)
Ethinamide
Ethionamid prothionamid
ethionamide
Ethionamide (JP15/USP/INN)
Ethionamide (JP17/USP/INN)
Ethionamide [USAN:INN:BAN:JAN]
Ethionamide [USAN:USP:INN:BAN:JAN]
Ethionamide for system suitability, European Pharmacopoeia (EP) Reference Standard
Ethionamide, European Pharmacopoeia (EP) Reference Standard
Ethionamide, United States Pharmacopeia (USP) Reference Standard
Ethionamidum
Ethionamidum [INN-Latin]
Ethioniamide
Ethylisothiamide
Ethyonomide
Etimid
Etiocidan
Etionamid
Etionamida
Etionamida [INN-Spanish]
Etionamide
Etionamide [DCIT]
Etioniamid
Etionid
Etionizin
Etionizina
Etionizine
F.I. 58-30
Fatoliamid
FCH919543
FS-1770
GA6196
HE349803
HMS1569J13
HMS1920M22
HMS2091F03
HMS2096J13
HMS2231F10
HMS2233J11
HMS3259K17
HMS3370I18
HMS3371D12
HMS3655M10
HMS500H07
HSDB 7473
HY-B0276
IDI1_000145
InChI=1/C8H10N2S/c1-2-7-5-6(8(9)11)3-4-10-7/h3-5H,2H2,1H3,(H2,9,11)
Iridocin
Iridocin Bayer
Iridozin
Isonicotinamide, 2-ethyl, thio-
Isonicotinamide, 2-ethylthio-
Isonicotinimidic acid, 2-ethylthio-
Isothin
Isotiamida
Itiocide
KB-50586
KBio1_000145
KBio2_001562
KBio2_004130
KBio2_006698
KBio3_001236
KBioGR_001213
KBioSS_001562
KS-00000FAO
KSC492I0R
LS-199
M381
MCULE-1322319906
MFCD00057361
MLS000069764
MLS001074114
MLS002454402
MolPort-000-159-777
NC00508
NCGC00016497-01
NCGC00016497-02
NCGC00016497-03
NCGC00016497-04
NCGC00016497-05
NCGC00016497-06
NCGC00016497-08
NCGC00016497-09
NCGC00091074-01
NCGC00091074-02
NCGC00091074-03
NCGC00091074-04
NCGC00256600-01
NCGC00259958-01
NCI-C01694
Nicotion
NINDS_000145
Nisotin
Nizotin
NSC 255115
NSC-255115
NSC-757028
NSC255115
NSC757028
OAY8ORS3CQ
Opera_ID_632
Pharmakon1600-01500292
Prestwick_842
Prestwick0_000526
Prestwick1_000526
Prestwick2_000526
Prestwick3_000526
PubChem15920
Rigenicid
RTC-061432
s1777
SAM002554899
SBB055548
SBI-0051377.P003
SCHEMBL27007
Sertinon
SMR000058716
SMR001370750
SPBio_001087
SPBio_002432
Spectrum_001082
SPECTRUM1500292
Spectrum2_000994
Spectrum3_000428
Spectrum4_000547
Spectrum5_000979
SR-01000759219
SR-01000759219-2
ST24046699
ST50949989
TC-061432
Teberus
TH 1314
Thianid
Thianide
Thioamide
Thiodine
Thiomid
Thioniden
Tianid
Tio-Mid
Tiomid
Tox21_110458
Tox21_110458_1
Tox21_202409
Tox21_302769
Trecator SC
Trecator-SC
Trecator-SC (TN)
Trekator
Trescatyl
Trescazide
Tubenamide
Tubermin
Tuberoid
Tuberoson
UNII-OAY8ORS3CQ
W-105719
WLN: T6NJ B2 DYZUS
Wyeth Brand of Ethionamide
ZINC3872520

US Patents and Regulatory Information for TRECATOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms TRECATOR ethionamide TABLET;ORAL 013026-002 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
Boehringer Ingelheim
Accenture
Harvard Business School
US Department of Justice
Merck
Johnson and Johnson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.